Sunday 29 May 2016
Membership
Membership in the NASSHP is open to all clinicians and scientists who have an interest in the study of hypertensive complications of pregnancy and its related fields.
Read more ...
Events
NASSHP's 2015 Scientific Meeting is on October 16, 2015 in Chicago, Illinois.
Read more ...
President's Page
News and information about NASSHP, directly from the Society's 2014-2016 President, Eugene Chang, MD.
Read more ...

________________________________________________________________________

  • Increase font size
  • Default font size
  • Decrease font size
Print

Events

Hypertension Forum at SMFM meeting, see agenda here

Hypertension Scientific Forum at SMFM meeting
Wednesday, February 3, 2016
3:00pm-6:00pm

 

 Itinerary

300-320p

Linking Preeclampsia Biomarkers with Therapy, Dr. Ravi Thadhani, MD, MPH

330-350p

Angiogenic factors and adverse outcomes related to hypertension, Dr. Sarosh Rana, MD, MPH

350-410p

Management of severe hypertension, Dr. Arun Jeyabalan, MD

410-420p

Panel Discussion

420-440p

Individual Patient Data Meta analysis for prediction of preeclampsia, Shakila Thangaratinam, PhD

440-500p

iHOPE International Collaboration to Harmonize Outcomes for Preeclampsia, James Duffy

500-520p Preeclampsia Registry, Eleni Tsigas

 Prior Events:


2015 NASSHP Conference
Preeclampsia and Hypertension in Pregnancy

The NASSHP Conference on Preeclampsia and Hypertension in Pregnancy was held October 16 – 18, 2015 at the Gwen Hotel (formerly the Conrad) in downtown Chicago, IL.  Approximately 75 attended this biannual meeting which had multiple objectives.  It focused on individuals in training and junior faculty considering career choices relating to high blood pressure in pregnancy, where they met with established investigators.  It created a rare opportunity where individuals in the basic and clinical sciences from diverse disciplines were able to interact.  It also updated practitioners on the latest advances in managing pregnant hypertensives.

The program featured 18 speakers, plus oral presentations and a poster session.  Those speaking formally included experts in the field:  Drs. Irina Alexandra Buhimschi, Maurice Druzin, Tom R. Easterling, Joey Granger, Arun Jeyabalan, Belinda Jim, S Ananth Karumanchi, Marshall Lindhiemer, Michael J Paidas, Sarosh Rana, Jim Roberts, Mark K. Santillan, Ellen Seely, Sajid Shahul, Jason Umans,  Stefan Verlohren, Doug Woelkers, Yang Xia

Meeting schedule:

Click here for a printable version of the full program

Friday

10/16/2015

5:00 pm

Registration / Welcome Reception
Welcome from local organizer and NASSHP President

7:00 pm

Enjoy Chicago!

 

 

Saturday

10/17/2015

7:00 am

Breakfast

 

7:50 am

Opening Remarks - Sarosh Rana

 

8:00 am

Current Opinion - Management of Hypertension in Pregnancy
Moderators:  Douglas Woelkers and Marshall Lindheimer
8-8:40 Status of the task force - Jim Roberts
8:45-9:25 Use of anti-hypertensive drugs in pregnancy, when/how/why - Jason Umans
9:30-10:10 Update on Preeclampsia Management:
CA toolkit/ACOG Taskforce - Maurice Druzin
10:10-10:20 Questions

 

 

10:20 am

Break

 

10:40

Oral Session 1
Moderators:  Sarosh Rana and Eugene Chang
10:40-11:00 Postpartum hypertension and preeclampsia - Arun Jeyabalan
11:00-12:00 Oral Presentation-Abstracts

 

12:30 pm

Lunch

2:00 pm

Oral Session II - Newer advances in Diagnostics in Preeclampsia
Moderator:  Ananth Karumanchi
2:00-2:20 sFit1/PIGF in prediction of adverse outcomes - Sarosh Rana
2:20-2:40 Management of preeclampsia with the sFit-1/PIGF ratio - Stefan Verlohren
2:40-3:00 Pelican Study/Petra - Doug Woelkers
3:00-3:20 Podocyturia in predicting preeclampsia, fact or fiction - Belinda Jim
3:20-3:40 Questions

3:40 pm

Break

4:00 pm

Oral Session III - Potential therapeutics & cardiovascular diseases &
preeclampsia
Moderator:  Joey P. Granger
4:00-4:20 Potential therapeutic value of the heme oxygenase system - Joey P. Granger
4:20-4:40 Prospecive randomized double-blind, placebo controlled evaluation of
the pharmacokinetics, safety and efficacy of recombinant antithrombin
versus placebo in preterm preeclampsia - Michael J. Paidas
4:40-5:00 Cardiac dysfunction with women with hypertensive disorders - Sajid Shahul
5:00-5:20 Strategies & barriers to CVD prevention in women with prior
preeclampsia - Ellen Seely
5:20-5:40 Questions

 

5:40 pm

Poster Session

 

 

7:30 pm

Awards Dinner
Young Investigator Awards presented by Dr. Marshall Lindheimer
Preeclampsia Foundation Vision Grant Awards presented by Dr. Tom Easterling

   

 

Sunday

10/18/2015

7:00 am

Breakfast

7:50 am

Opening Remarks - Sarosh Rana

8:00 am

Oral Session IV: Preeclampsia in Developing world - Trials
Moderator:  Tom Easterling
8:00-8:40 Preeclampsia in developing world - trials - Tom Easterling
8:45-9:40 Oral Presentation-Abstracts

9:40 am

Break

 

10:20 am

Oral Session V: New Biology of Preeclampsia
Moderator:  Irini Buhimschi
10:00-10:20 Angiotensin receptor, autoimmunity and preeclampsia - Yang Xia
10:20-10:40 Protein misfolding in preeclampsia - Irina Buhimschi
10:40-11:00 Vasopressin:  The Missing Link for preeclampsia - Mark Santillan
11:00-11:20 Questions

11:20 am

Meeting concludes

 

Speaker Presentations (links in alphabetical order by last name of presenter):

Bajracharya

Buhimschi

Druzin

Jeyabalan

Jim

Lee

Paidas

Roberts

Santillan

Umans

 


NASSHP's 2013 Scientific Meeting

NASSHP's 2013 Scientific Meeting was FridaySept 13 - Sunday, Sept 15, 2013 at the historical landmark, Le Place D’Armes Hotel in Montreal, Québec, Canada.  In addition, prior to the Annual Meeting, a CME for Clinicians was offered on Friday, Sept 13, 2013.

The 2013 Annual Scientific Meeting was filled with robust plenary discussions, several detailed research study sessions, and also included the awarding of six (6) competitive travel awards of $400 each to Young Investigators with submission of oral presentation and documentation of trainee status. 

Finalized meeting schedule:


 

CME/Clinicians' Seminar:

Last year, GEMOQ and ASMIQ offered a full 9-hour day of clinicians' seminars on Friday, Sept 13, between 8:00am and 5:00pm. Paid CME registration included a detailed syllabus filled with interactive presentations, case histories, panel discussions, question & answer sessions. Breakfast, lunch, and break refreshments were served and included in paid registration, as well.

Final CME schedule:

 



 

2012 Society Meeting a Success

The Society's September 7-9th, 2012 meeting at Kiawah Island, SC fostered communication and collaboration between junior investigators and more experienced investigators.

The 2012 society meeting for the NASSHP was held September 7-9th, 2012 at Kiawah Island just south of Charleston, South Carolina. The meeting was an excellent venue for junior and more experienced investigators alike, and the location was superb. Issuing three Young Investigator Awards at this year's meeting, the NASSHP again demonstrated how very supportive they are of junior investigators involved in preeclampsia research. This meeting continued the tradition of sponsoring a smaller meeting in order to allow expert presentations and small group seminars to take place in an informal setting. Communication and collaboration between junior investigators and more experienced investigators was fostered.

Speakers present and topics covered during our 2012 meeting were:

Rob Powers.  “Framing the Question”

Scott Walsh.  “Neutrophils: Critical Mediators of Vascular Dysfunction in Preeclampsia”

Kyu-Ho Lee.  “Congenital Outflow Tract Abnormalities and Their Link to Preeclampsia”

Sarosh Rana.  “Angiogenic factors and Preeclampsia Evaluation in Triage”

Don Job.  "Computer-based tools for evaluating risk"

Surendra Sharma.  “A ‘humanized’ Mouse Model and Novel Approaches for Preeclampsia”

Liliya M. Yamaleyeva.  “ACE2 Deficiency Enhances Angiotensin II-Induced Vasoconstriction of the Uterine Artery at Mid- Gestation in Mice”

Sajid Shahul. "Subclinical Left Ventricular Dysfunction in Preeclamptic Women with Preserved  Left Ventricular Ejection Fraction: A 2D Speckle Tracking Imaging Study”

Eleni Tsigas.  “Preeclampsia Registry and BioBank: Investing Now”

Ellen Seely.  "Increased Angiotensin II Sensitivity Predisposes Women with Prior Preeclampsia to Future Cardiovascular Disease"

Richard M. Burwick.  “Elevated Urinary C5a Levels in Severe Preeclampsia / HELLP Syndrome Are Not Associated with Clinical Measures of Renal Impairment”

Deepa Shah.  “Acute Pulmonary Edema Is More Common In Women With Eclampsia If Initial Care Is Rendered At A Small Rural Hospital Compared To A Tertiary Care Center”

Marshall Lindheimer. “The History Of Preeclampsia As Seen By A Nephrologist”

**************************************************************************

The Annual NASSHP Meeting was created as a regular opportunity for clinicians and researchers in the fields of preeclampsia and hypertensive disorders of pregnancy to meet, share information and advance the state of knowledge. The meeting format is structured as a series of expert presentations and small group seminars during which attendees are asked to contribute their latest findings and ideas. Group leaders are encouraged to interact with their participants in order to make each session a successful discussion experience.

The informal and collegial atmosphere of these meetings is especially intended to facilitate communication between established and more junior investigators who may be newly independent or still in training. To this purpose, the NASSHP reserves young investigator grants solely for this purpose.